Improved Sleep for Obesity and Diabetes Risk Reduction
Trial Summary
What is the purpose of this trial?
The goal of this study is to identify an intervention that improves sleep health and consequently metabolic health by examining whether sleep extension or enforced regularity in short sleepers will have beneficial effects on diabetes and obesity risk.
Research Team
Erin Hanlon, Ph.D.
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for African American adults aged 21-50 who are overweight with a BMI of 25 to 30 and usually sleep less than 7 hours at night. Participants should have the potential to sleep more if they had the time.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline/Habitual Sleep Assessment
Assessment of sleep duration, food intake, hunger/appetite ratings, reward-related eating, daily interstitial glucose, resting metabolic rate, insulin sensitivity, and glucose tolerance
Intervention
Participants are randomized to either sleep extension or sleep regularity intervention for 14 days
Post-Intervention Assessment
Reassessment of food intake, hunger/appetite ratings, reward-related eating, daily interstitial glucose, resting metabolic rate, insulin sensitivity, and glucose tolerance
Follow-up
Participants are monitored for changes in sleep and metabolic health outcomes
Treatment Details
Interventions
- Sleep Extension
- Sleep Regularity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor